technetium tc 99m hydroxymethylene diphosphonate has been researched along with Muscular Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boy, C; Dafotakis, M; Eickhoff, SB; Fink, GR; Nikolin, S; Sparing, R | 1 |
| al-Nahhas, AM; Anagnostopoulos, C; Heary, T; Hirsch, W; Jinnouchi, S; McCready, VR | 1 |
| Martínez Carsí, C; Muñoz Moliner, J; Ruíz Hernández, G; Sánchez Marchori, C | 1 |
| Chung, YA; Kim, EN; Park, JM; Sohn, HS | 1 |
4 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and Muscular Diseases
| Article | Year |
|---|---|
Postinfectious focal necrotizing myopathy.
Topics: Adult; Biopsy; Common Cold; Electromyography; Female; Humans; Inflammation; Muscle, Skeletal; Muscular Diseases; Necrosis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Time Factors | 2008 |
Clinical significance of technetium-99m methylene diphosphonate myocardial uptake: association with carcinoma of the prostate.
Topics: Aged; Aged, 80 and over; Bone and Bones; Bone Diseases; Case-Control Studies; Female; Heart; Humans; Male; Muscular Diseases; Neoplasms; Prostatic Neoplasms; Radionuclide Imaging; Technetium Tc 99m Medronate | 1995 |
Rhabdomyolysis in DOMS.
Topics: Adult; Bone and Bones; Humans; Joint Diseases; Magnetic Resonance Imaging; Male; Muscular Diseases; Pain; Radionuclide Imaging; Radiopharmaceuticals; Rhabdomyolysis; Running; Technetium Tc 99m Medronate | 1999 |
Muscular sarcoidosis: Ga-67 scintigraphy and magnetic resonance imaging.
Topics: Adult; Bone and Bones; Citrates; Gallium; Gallium Radioisotopes; Humans; Lung; Magnetic Resonance Imaging; Male; Muscle, Skeletal; Muscular Diseases; Radionuclide Imaging; Radiopharmaceuticals; Sarcoidosis; Technetium Tc 99m Medronate | 2001 |